Titan Biotech Limited has updated its board committee structures. The company's Board approved the reconstitution of four key committees: Audit, Nomination & Remuneration, Corporate Social Responsibility, and Stakeholders Relationship. Mr. Brijesh Kumar Singh and Mr. Debendra Kumar Sabat have been appointed as new members to all these committees. Both are Independent Directors. This move strengthens corporate governance and oversight across critical operational and strategic functions, ensuring robust independent representation on committees vital for investor confidence and company management.